Immunomedics Must Face Suit Over Founder’s Severance, Settlement

April 19, 2021, 9:45 PM

Immunomedics Inc. lost its bid Monday to escape claims in Delaware Chancery Court that it repeatedly breached its founder’s severance package and a settlement deal resolving earlier litigation over his ouster after a hedge fund’s hostile takeover.

Vice Chancellor J. Travis Laster let most of the lawsuit move forward, saying Dr. David M. Goldenberg offered a reasonable reading—in some instances the only one—of provisions requiring the company to pay him after his departure and give him a cut of future asset sales, including royalties.

Laster also refused to rule out holding Immunomedics in contempt for breaches of Goldenberg’s employment agreement,...

To read the full article log in.

Learn more about a Bloomberg Law subscription.